Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial (Q38787993)
Jump to navigation
Jump to search
scientific article published on 10 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial |
scientific article published on 10 May 2017 |
Statements
1 reference
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial (English)
1 reference
Toyoaki Hida
1 reference
Hiroshi Nokihara
1 reference
Masashi Kondo
1 reference
Young Hak Kim
1 reference
Koichi Azuma
1 reference
Takashi Seto
1 reference
Yuichi Takiguchi
1 reference
Makoto Nishio
1 reference
Hiroshige Yoshioka
1 reference
Fumio Imamura
1 reference
Katsuyuki Hotta
1 reference
Satoshi Watanabe
1 reference
Koichi Goto
1 reference
Miyako Satouchi
1 reference
Toshiyuki Kozuki
1 reference
Takehito Shukuya
1 reference
Kazuhiko Nakagawa
1 reference
Tetsuya Mitsudomi
1 reference
Nobuyuki Yamamoto
1 reference
Takashi Asakawa
1 reference
Ryoichi Asabe
1 reference
Tomohiro Tanaka
1 reference
Tomohide Tamura
1 reference
10 May 2017
1 reference
1 reference
390
1 reference
10089
1 reference
29-39
1 reference
Identifiers
1 reference
1 reference